LTB4R2 and intrahepatic cholangiocarcinoma: We first examined the effects of ICC-CM or LTB4 on the migration and invasion of M2 macrophages (derived from THP-1) treated with U75302 (LTB4R inhibitor) and LY255283 (LTB4R2) inhibitors.